These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Specific memory deficits in ecstasy users? The results of a meta-analysis. Verbaten MN Hum Psychopharmacol; 2003 Jun; 18(4):281-90. PubMed ID: 12766933 [TBL] [Abstract][Full Text] [Related]
25. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage? Gouzoulis-Mayfrank E; Daumann J Addiction; 2006 Mar; 101(3):348-61. PubMed ID: 16499508 [TBL] [Abstract][Full Text] [Related]
26. Differential effects of ecstasy on short-term and working memory: a meta-analysis. Nulsen CE; Fox AM; Hammond GR Neuropsychol Rev; 2010 Mar; 20(1):21-32. PubMed ID: 20157852 [TBL] [Abstract][Full Text] [Related]
27. Temporal and visual source memory deficits among ecstasy/polydrug users. Fisk JE; Gallagher DT; Hadjiefthyvoulou F; Montgomery C Hum Psychopharmacol; 2014 Mar; 29(2):172-82. PubMed ID: 24446108 [TBL] [Abstract][Full Text] [Related]
28. Discrete memory impairments in largely pure chronic users of MDMA. Wunderli MD; Vonmoos M; Fürst M; Schädelin K; Kraemer T; Baumgartner MR; Seifritz E; Quednow BB Eur Neuropsychopharmacol; 2017 Oct; 27(10):987-999. PubMed ID: 28866005 [TBL] [Abstract][Full Text] [Related]
31. The relationships of 'ecstasy' (MDMA) and cannabis use to impaired executive inhibition and access to semantic long-term memory. Murphy PN; Erwin PG; Maciver L; Fisk JE; Larkin D; Wareing M; Montgomery C; Hilton J; Tames FJ; Bradley B; Yanulevitch K; Ralley R Hum Psychopharmacol; 2011 Oct; 26(7):460-9. PubMed ID: 21898599 [TBL] [Abstract][Full Text] [Related]
32. Neurocognitive function in current and ex-users of ecstasy in comparison to both matched polydrug-using controls and drug-naïve controls. Hoshi R; Mullins K; Boundy C; Brignell C; Piccini P; Curran HV Psychopharmacology (Berl); 2007 Oct; 194(3):371-9. PubMed ID: 17605005 [TBL] [Abstract][Full Text] [Related]
33. Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function. Curran HV; Verheyden SL Psychopharmacology (Berl); 2003 Aug; 169(1):91-103. PubMed ID: 12759801 [TBL] [Abstract][Full Text] [Related]
34. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence? Morgan MJ; McFie L; Fleetwood H; Robinson JA Psychopharmacology (Berl); 2002 Jan; 159(3):294-303. PubMed ID: 11862362 [TBL] [Abstract][Full Text] [Related]
35. Meta-analysis of executive functioning in ecstasy/polydrug users. Roberts CA; Jones A; Montgomery C Psychol Med; 2016 Jun; 46(8):1581-96. PubMed ID: 26966023 [TBL] [Abstract][Full Text] [Related]
36. Cerebral activation in abstinent ecstasy (MDMA) users during a working memory task: a functional magnetic resonance imaging (fMRI) study. Daumann J; Fimm B; Willmes K; Thron A; Gouzoulis-Mayfrank E Brain Res Cogn Brain Res; 2003 May; 16(3):479-87. PubMed ID: 12706227 [TBL] [Abstract][Full Text] [Related]
38. Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study. Schilt T; de Win MM; Koeter M; Jager G; Korf DJ; van den Brink W; Schmand B Arch Gen Psychiatry; 2007 Jun; 64(6):728-36. PubMed ID: 17548754 [TBL] [Abstract][Full Text] [Related]
39. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective. Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479 [TBL] [Abstract][Full Text] [Related]